Elite Pharmaceuticals IncOTCQB:ELTP
- LAST PRICE0.1335
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.1354 / 0.1335
- Day Range
- 52 Week Range
- Volume85,713
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ELTP |
|---|---|---|
| 09:32 ET | 700 | 0.1354 |
| 09:43 ET | 10000 | 0.13317 |
| 09:54 ET | 384 | 0.1345 |
| 10:03 ET | 2000 | 0.1347 |
| 10:08 ET | 500 | 0.1347 |
| 10:17 ET | 280 | 0.13416 |
| 10:32 ET | 10000 | 0.136035 |
| 10:35 ET | 200 | 0.136035 |
| 10:46 ET | 300 | 0.136035 |
| 10:57 ET | 500 | 0.1342 |
| 11:06 ET | 1000 | 0.13575 |
| 11:26 ET | 250 | 0.13575 |
| 11:40 ET | 8500 | 0.1345 |
| 11:47 ET | 100 | 0.134475 |
| 12:02 ET | 3328 | 0.134475 |
| 01:08 ET | 5000 | 0.134025 |
| 03:12 ET | 2485 | 0.135 |
| 03:36 ET | 2000 | 0.135 |
| 03:41 ET | 1000 | 0.134025 |
| 03:54 ET | 37000 | 0.1335 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Elite Pharmaceuticals Inc | 135.9M | 8.7x | --- |
Eton Pharmaceuticals Inc | 78.6M | -78.7x | --- |
Dbv Technologies SA | 128.8M | -1.7x | --- |
Zevra Therapeutics Inc | 195.4M | -3.5x | --- |
Scilex Holding Co | 149.6M | -0.7x | --- |
Cumberland Pharmaceuticals Inc | 23.4M | -3.7x | --- |
Company Information
Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and distributes niche generic products. The Company specializes in developing and manufacturing oral, controlled-release drug products. It owns multiple generic products which has been licensed to Prasco, LLC and TAGI Pharma. The Company’s segments include Abbreviated New Drug Applications (ANDA) and New Drug Application (NDA). The Company’s products include Phentermine HCl 37.5mg tablets, Phendimetrazine Tartrate 35mg tablets, Phentermine HCl 15mg and 30mg capsules, Naltrexone HCl 50mg tablets, Trimipramine Maleate Immediate Release 25mg, 50mg and 100mg capsules, Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Immediate Release 5mg, 7.5mg, 10mg, 12.5mg, 15mg, 20mg and 30mg tablets, Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended Release 5mg, 10mg, 15mg, 20mg, 25mg, and 30mg capsules and others.
Contact Information
- Headquarters
- 165 Ludlow AveNORTHVALE, NJ, United States 07647-2305
- Phone
- 201-750-2646
- Fax
- ---
Executives
- Chairman of the Board, President, Chief Executive Officer
- Nasrat Hakim
- Chief Financial Officer, Treasurer, Company Secretary
- Carter Ward
- Executive Vice President - Operations
- Douglas Plassche
- Chief Commercial Officer
- Kirko Kirkov
- Independent Director
- Davis Caskey
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $135.9M |
|---|---|
Revenue (TTM) | $47.3M |
Shares Outstanding | 1.0B |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.09 |
EPS | $0.02 |
Book Value | $0.03 |
P/E Ratio | 8.7x |
Price/Sales (TTM) | 2.9 |
Price/Cash Flow (TTM) | 8.0x |
Operating Margin | 17.83% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
